Your browser doesn't support javascript.
loading
Compatibility of Meropenem with Different Commercial Peritoneal Dialysis Solutions.
Wiesholzer, Martin; Winter, Alexandra; Kussmann, Manuel; Zeitlinger, Markus; Pichler, Petra; Burgmann, Heinz; Reznicek, Gottfried; Poeppl, Wolfgang.
Afiliación
  • Wiesholzer M; Department of Internal Medicine I, University hospital St. Poelten, Karl Landsteiner University of Health Sciences, St. Poelten, Austria.
  • Winter A; Department of Pharmacognosy, University of Vienna, Vienna, Austria.
  • Kussmann M; Department of Internal Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University Vienna, Vienna, Austria.
  • Zeitlinger M; Department of Clinical Pharmacology, Medical University Vienna, Vienna, Austria.
  • Pichler P; Department of Internal Medicine I, University hospital St. Poelten, Karl Landsteiner University of Health Sciences, St. Poelten, Austria.
  • Burgmann H; Department of Internal Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University Vienna, Vienna, Austria.
  • Reznicek G; Department of Pharmacognosy, University of Vienna, Vienna, Austria gottfried.reznicek@univie.ac.at.
  • Poeppl W; Department of Internal Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University Vienna, Vienna, Austria.
Perit Dial Int ; 37(1): 51-55, 2017.
Article en En | MEDLINE | ID: mdl-27605684
ABSTRACT
♦

BACKGROUND:

Intraperitoneal administration of antimicrobial agents is recommended for the treatment of peritoneal dialysis (PD)-related peritonitis. For home-based antimicrobial therapy it is common to supply patients with PD fluid bags with admixed antibiotic. Thus, the compatibility of meropenem with different PD fluids (PDFs), namely Extraneal, Physioneal 1.36% and Physioneal 2.27% (all Baxter Healthcare Corp., Deerfield, IL, USA), was investigated under varying storage conditions. ♦

METHODS:

Meropenem (Venus Pharma, Werne, Germany) was stored at 6°C and 25°C over 14 days and at 37°C over 24 hours. Drug concentration over time was determined using high performance liquid chromatography, drug activity by a diffusion disk method, diluent stability by visual inspection and drug adsorption was calculated. Blank PD fluids and deionized water were used as comparator solutions. ♦

RESULTS:

Compared to water, the stability of meropenem was minimally lower in Extraneal but markedly reduced in both Physioneal solutions. No significant drug adsorption was detected for any PDF investigated. ♦

CONCLUSIONS:

Meropenem is stable and compatible with Extraneal and might be stored for up to a week at refrigeration temperature (6°C). A loss of ~20% of meropenem after 2 days at room temperature should be considered. Mixed Physioneal appears not suitable for storage at any temperature after meropenem has been admixed. A considerable drug degradation due to the warming up to body temperature through heating plates should further be taken into account in clinical practice.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Peritonitis / Soluciones para Diálisis / Tienamicinas / Estabilidad de Medicamentos / Antibacterianos Tipo de estudio: Diagnostic_studies / Etiology_studies Límite: Humans Idioma: En Revista: Perit Dial Int Asunto de la revista: NEFROLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Austria

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Peritonitis / Soluciones para Diálisis / Tienamicinas / Estabilidad de Medicamentos / Antibacterianos Tipo de estudio: Diagnostic_studies / Etiology_studies Límite: Humans Idioma: En Revista: Perit Dial Int Asunto de la revista: NEFROLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Austria
...